Atlas Discovery
AI-native pharma company
About Atlas Discovery
AI-native pharma company
Public traction evidence
Each signal links to the public source used for attribution.
- X
Nine out of ten drugs fail in clinical trials. The reason isn't a shortage of data. It's that none of it connects. We started Atlas Disc...
Nine out of ten drugs fail in clinical trials. The reason isn't a shortage of data. It's that none of it connects. We started Atlas Discovery to fix that with foundation models of patient drug response. We're backed by @ycombinator, @pearvc, and more.
- X
Nine out of ten drugs fail in clinical trials because we can’t predict how a patient will respond.
Nine out of ten drugs fail in clinical trials because we can’t predict how a patient will respond. We backtested our foundation model of patient biology on multiple clinical trials in Cancer and Autoimmune diseases and successfully separated responders vs non-responders 70-90% of
- LinkedIn
Founder says he started Atlas Discovery. Post says Atlas Discovery raised funding from Y Combinator.
Founder says he started Atlas Discovery. Post says Atlas Discovery raised funding from Y Combinator.
- X
Today we're excited to announce our partnership with Alliance to Cure.
Today we're excited to announce our partnership with Alliance to Cure. Our biomedical research agents found a novel drug repurposing candidate for Cerebral Cavernous Malformation and the foundation is now running preclinical tests on it!
- X
Humanity’s greatest gains from AI will emerge from healthcare.
Humanity’s greatest gains from AI will emerge from healthcare. Today we’re sharing ClinicBench go evaluate frontier agents’ ability to reason over a patient’s medical history and recommend clinical actions. This is a product of our RL environment for clinical decision agents.
- X
Today, we're excited to share our work on agents for drug repurposing.
Today, we're excited to share our work on agents for drug repurposing. In 2019, a diabetes drug (dapagliflozin) turned out to keep heart failure patients alive, and our biomedical research agents recovered it from first principles.
- X
We’re building foundation models that predict patient response in clinical trials. Excited for the future at @atlasdiscovery0 with @ShaamilKarim1 and @Cgensbigler ! Quote Atlas Discovery @atlasdiscovery0 · Jun 23 Nine out of ten drugs fail in clinical trials. The reason isn't a shortage of data. It's that none of it connects. We started Atlas Discovery to fix that with foundation models of patient drug response. We're backed by @ycombinator, @pearvc, and more.
We’re building foundation models that predict patient response in clinical trials. Excited for the future at @atlasdiscovery0 with @ShaamilKarim1 and @Cgensbigler ! Quote Atlas Discovery @atlasdiscovery0 · Jun 23 Nine out of ten drugs fail in clinical trials. The reason isn't a...
- X
We trained a foundation model of patient biology that predicts drug response from a single biopsy before treatment.
We trained a foundation model of patient biology that predicts drug response from a single biopsy before treatment. As a case study, we tested on a phase 3 trial of ustekinumab in IBD and get a 0.76 AUROC, enough to run it with ~450 fewer patients at the same statistical power....